These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21178963)

  • 21. Diffuse mesenterial sclerosis: a characteristic feature of chronic small-bowel allograft rejection.
    Klaus A; Margreiter R; Pernthaler H; Klima G; Offner FA
    Virchows Arch; 2003 Jan; 442(1):48-55. PubMed ID: 12536314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation.
    Schmid C; Heemann U; Tilney NL
    Transplantation; 1997 Jul; 64(2):222-8. PubMed ID: 9256177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study.
    Miller KK; Wang D; Hu X; Hua X; Deuse T; Neofytou E; Renne T; Velden J; Reichenspurner H; Schrepfer S; Bernstein D
    Transpl Int; 2017 Nov; 30(11):1181-1189. PubMed ID: 28672061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat heart-aorta cluster transplantation: a novel model to study transplant rejection.
    D'Silva M; Candinas D; Lee S; Achilleos O; Bonnet P; Antoniou E; Mayer D; McMaster P
    Transpl Int; 1995; 8(4):298-306. PubMed ID: 7546153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium Sulfite Exacerbates Allograft Vasculopathy and Affects Tryptophan Breakdown in Murine Heterotopic Aortic Transplantation.
    Sucher R; Hautz T; Mohr E; Mackowitz M; Mellitzer V; Steger C; Cardini B; Resch T; Margreiter C; Schneeberger S; Brandacher G; Fuchs D; Oberhuber R; Gostner JM
    Oxid Med Cell Longev; 2019; 2019():8461048. PubMed ID: 31089419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection.
    Khattar M; Baum CE; Schroder P; Breidenbach JD; Haller ST; Chen W; Stepkowski S
    PLoS One; 2019; 14(11):e0225624. PubMed ID: 31756235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J; Suzuki C; Kudou S; Yasue T; Hakamata Y; Takahashi M; Murakami T; Hashizume K; Kobayashi E
    J Heart Lung Transplant; 2006 Jul; 25(7):825-33. PubMed ID: 16818126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed hematopoietic chimerism prevents allograft vasculopathy.
    Kawaharada N; Shears LL; Li S; Pham SM
    J Heart Lung Transplant; 1999 Jun; 18(6):532-41. PubMed ID: 10395351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
    Hariya A; Takazawa K; Yamamoto T; Amano A
    J Heart Lung Transplant; 2004 Oct; 23(10):1163-9. PubMed ID: 15477110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.
    Fritz NM; Stamminger T; Ramsperger-Gleixner M; Kuckhahn AV; Müller R; Weyand M; Heim C
    Transpl Immunol; 2021 Feb; 64():101359. PubMed ID: 33301898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
    Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-4 expression delays eosinophil-independent vasculopathy and fibrosis during allograft rejection in the mouse.
    Roberts EM; Hall DS; Ferguson S; Minson S; Davies JD
    J Clin Immunol; 2003 Mar; 23(2):119-31. PubMed ID: 12757264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
    Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blockade of B7:CD28 costimulatory pathway reduces the vascular damage in an experimental model of chronic rejection].
    Rademacher J; Cansolino L; Lillo E; Oldani G; Delfino A; Matteotti C; Gaspari A; Maestri M; Dionigi P
    Minerva Chir; 2005 Dec; 60(6):487-96. PubMed ID: 16402003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
    Hare GM; Lee TD; Jordan JL; Hirsch GM
    Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
    [No Abstract]   [Full Text] [Related]  

  • 36. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells in acute and chronic rejection of rat cardiac allografts--a major source of basic fibroblast growth factor.
    Koskinen PK; Kovanen PT; Lindstedt KA; Lemström KB
    Transplantation; 2001 Jun; 71(12):1741-7. PubMed ID: 11455252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of chronic rejection by antibody induced vascular accommodation in fully allogeneic heart allografts.
    Semiletova NV; Shen XD; Baibakov B; Feldman DM; Mukherjee K; Frank JM; Stepkowski SM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplantation; 2005 Dec; 80(11):1535-40. PubMed ID: 16371921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats.
    Harrison PC; Madwed JB
    J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.